Doxycycline 40 delayed release capsule

Doxycycline delayed release capsule, for oral administration, consisting of: 40mg/capsule doxycycline. Indications: ORACEA is a tetracycline class drug indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients (1.1) Efficacy of ORACEA beyond 16 weeks and safety beyond 9 months have not been established (1.2) This formulation of doxycycline has not been evaluated in the treatment or prevention o... More

Active ingredients:

Routes of administration:

Dosage form:

Drug formulation

Strength:

Strength value Strength units Active ingredient
  • 40
  • mg/capsule

Brand names:

  • Oracea

Drug category:

Formulation of:

Active ingredient moieties:

Legal status:

Manufactured forms:

top ↑

You can help improve this topic by adding more facts here

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!